Grand Rapids Press (Internet / Print) 06/14/06 Column by Dr. Howard Brody: The ideal research study measures outcomes of real importance to people -- how many died, how many had strokes and heart attacks. The outcome measured in Julius's study was whether Atacand slowed the progression to "real" hypertension if you started with prehypertension. For that, the drug worked. But we have no idea whether any of these people is healthier as a result. We don't know if waiting until they developed hypertension, then treating them, would have done just as well. And, most important, the ideal treatment of "real" hypertension is cheap generic drugs, especially diuretics.